256 related articles for article (PubMed ID: 21471092)
1. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways.
Brandtzaeg P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1595-604. PubMed ID: 21471092
[TBL] [Abstract][Full Text] [Related]
2. The B-cell development in tonsillar lymphoid follicles.
Brandtzaeg P
Acta Otolaryngol Suppl; 1996; 523():55-9. PubMed ID: 9082810
[TBL] [Abstract][Full Text] [Related]
3. The Waldeyer's ring.
Hellings P; Jorissen M; Ceuppens JL
Acta Otorhinolaryngol Belg; 2000; 54(3):237-41. PubMed ID: 11082757
[TBL] [Abstract][Full Text] [Related]
4. Immune functions of nasopharyngeal lymphoid tissue.
Brandtzaeg P
Adv Otorhinolaryngol; 2011; 72():20-4. PubMed ID: 21865681
[TBL] [Abstract][Full Text] [Related]
5. Function of mucosa-associated lymphoid tissue in antibody formation.
Brandtzaeg P
Immunol Invest; 2010; 39(4-5):303-55. PubMed ID: 20450282
[TBL] [Abstract][Full Text] [Related]
6. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
[TBL] [Abstract][Full Text] [Related]
7. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know.
Brandtzaeg P
Int J Pediatr Otorhinolaryngol; 2003 Dec; 67 Suppl 1():S69-76. PubMed ID: 14662171
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.
Heritage PL; Brook MA; Underdown BJ; McDermott MR
Immunology; 1998 Feb; 93(2):249-56. PubMed ID: 9616375
[TBL] [Abstract][Full Text] [Related]
9. Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine.
Okada K; Yamasoba T; Kiyono H
Adv Otorhinolaryngol; 2011; 72():31-6. PubMed ID: 21865684
[TBL] [Abstract][Full Text] [Related]
10. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.
Wu HY; Nikolova EB; Beagley KW; Russell MW
Immunology; 1996 Aug; 88(4):493-500. PubMed ID: 8881748
[TBL] [Abstract][Full Text] [Related]
11. Implications of nasopharynx-associated lymphoid tissue (NALT) in the development of allergic responses in an allergic rhinitis mouse model.
Kim DY; Fukuyama S; Nagatake T; Takamura K; Kong IG; Yokota Y; Lee CH; Kiyono H
Allergy; 2012 Apr; 67(4):502-9. PubMed ID: 22257110
[TBL] [Abstract][Full Text] [Related]
12. Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation.
Butcher EC; Rouse RV; Coffman RL; Nottenburg CN; Hardy RR; Weissman IL
J Immunol; 1982 Dec; 129(6):2698-707. PubMed ID: 6982940
[TBL] [Abstract][Full Text] [Related]
13. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines.
Cisney ED; Fernandez S; Hall SI; Krietz GA; Ulrich RG
J Vis Exp; 2012 Aug; (66):3960. PubMed ID: 22871688
[TBL] [Abstract][Full Text] [Related]
14. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses.
Zuercher AW; Coffin SE; Thurnheer MC; Fundova P; Cebra JJ
J Immunol; 2002 Feb; 168(4):1796-803. PubMed ID: 11823512
[TBL] [Abstract][Full Text] [Related]
15. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue.
Fernandez S; Cisney ED; Hall SI; Ulrich RG
Clin Vaccine Immunol; 2011 Apr; 18(4):667-75. PubMed ID: 21325486
[TBL] [Abstract][Full Text] [Related]
16. The immunity of upper airways.
Canessa C; Vierucci S; Azzari C; Vierucci A
Int J Immunopathol Pharmacol; 2010; 23(1 Suppl):8-12. PubMed ID: 20152071
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method.
Petukhova G; Naikhin A; Chirkova T; Donina S; Korenkov D; Rudenko L
Vaccine; 2009 Apr; 27(19):2580-7. PubMed ID: 19428864
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: Uniqueness of lymphoid chemokine requirement for the initiation and maturation of nasopharynx-associated lymphoid tissue organogenesis.
Fukuyama S; Nagatake T; Kim DY; Takamura K; Park EJ; Kaisho T; Tanaka N; Kurono Y; Kiyono H
J Immunol; 2006 Oct; 177(7):4276-80. PubMed ID: 16982861
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunity: induction, dissemination, and effector functions.
Brandtzaeg P
Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
